Trial Profile
Clinical study to examine the changes of purine compounds by the simultaneous administration of xanthine oxidase/xanthine dehydrogenase inhibitors and inosine in healthy subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2017
Price :
$35
*
At a glance
- Drugs Allopurinol (Primary) ; Febuxostat (Primary) ; Topiroxostat (Primary)
- Indications Diabetic nephropathies; Gout; Hyperuricaemia
- Focus Therapeutic Use
- 28 Feb 2017 New trial record